Friday, December 26, 2025
ADVT 
National

No unexpected effects from COVID-19 shots so far

Darpan News Desk The Canadian Press, 08 Jan, 2021 06:26 PM
  • No unexpected effects from COVID-19 shots so far

Health Canada has no reports of unexpected side-effects from patients vaccinated against COVID-19 thus far.

"There haven't been any serious adverse events, or even the mild and moderate adverse events, that have been out of line or different than what we've seen in the clinical trials," Dr. Supriya Sharma said in an interview with The Canadian Press Friday.

Sharma, Health Canada's chief medical adviser, is overseeing the vaccine review process.

She said experts look for two things when reviewing data after vaccines are given. The first is whether anything happens that was not observed during the clinical trials, and the second is whether the side-effects that were documented during the trials are more severe or greater in number than what the trials saw.

The answer to both questions in Canada so far is no, said Sharma.

"It seems that the clinical trials are pretty representative," she said.

The most common side-effects from the vaccines are short-term fever, pain at the injection site, headache and fatigue. Most subside within 24 hours.

Health Canada approved two vaccines for COVID-19 in December, including one from Pfizer and BioNTech and a second from Moderna.

Vaccinations began Dec. 14, and data aggregated by University of Saskatchewan student Noah Little shows about 230,000 doses have been given so far. Most of the first doses went to front-line hospital staff and long-term care workers and a smaller number of long-term care residents.

Vaccines began reaching some First Nations and northern territories this week.

Health Canada continues to review data from two other vaccine developers, AstraZeneca and Johnson & Johnson, but is still awaiting more data from the companies. Sharma said she can't say when Health Canada would be ready to make a decision about either one.

Both companies are expected to complete Phase 3 clinical trials in the United States this month.

MORE National ARTICLES

Bloc MPs isolating after staffer gets COVID-19

Bloc MPs isolating after staffer gets COVID-19
The forced isolation of all Bloc MPs underscored the risk of having even a small number of MPs physically present in the chamber.

Bloc MPs isolating after staffer gets COVID-19

Kingswood to acquire Mountain Equipment Co-op

Kingswood to acquire Mountain Equipment Co-op
Vancouver-based MEC says the transition from a co-operative structure to a subsidiary of Kingswood Capital Management is needed to ensure a stable future for the business.

Kingswood to acquire Mountain Equipment Co-op

Dozens of people attempt to claim lost cash: RCMP

Dozens of people attempt to claim lost cash: RCMP
The Mounties had asked people to refrain from contacting police in attempts to guess those details, warning that their claims would constitute fraud.

Dozens of people attempt to claim lost cash: RCMP

Further lockdowns possible if COVID-19 cases keep rising: Ford

Further lockdowns possible if COVID-19 cases keep rising: Ford
The premier said the lockdowns would be regional, and not mirror the broad approach taken during the first wave of the virus in March.

Further lockdowns possible if COVID-19 cases keep rising: Ford

Experts assess the COVID risks of Halloween

Experts assess the COVID risks of Halloween
The scaled-back festivities are yet another blow to normal life wrought by the novel coronavirus, bemoans Vicente, who loves the holiday.

Experts assess the COVID risks of Halloween

$10M mark surpassed by Surrey Makes PPE manufacturers

$10M mark surpassed by Surrey Makes PPE manufacturers
The program’s goal is to ensure that critical PPE is produced, sourced and are readily available to Canadians.

$10M mark surpassed by Surrey Makes PPE manufacturers